EnteroBiotix
PrivateLast Round
Seed Round
Apr 9, 2026
Total Funding Raised
$59.09M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
EnteroBiotix is a biotechnology company that develops microbiome-modulating drugs aimed at restoring health and preventing bacterial infections through tailored high-diversity microbial therapeutics for patients with serious unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnteroBiotix Comparables
Compare EnteroBiotix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiotica | 85% | |
| BiomeBank | 83% | |
| Human Biome S.A. | 82% |
EnteroBiotix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 9, 2026 | ||||
| Series B | Apr 4, 2024 | ||||
| Series A | Sep 7, 2021 | ||||
| Seed | May 29, 2019 | ||||
| Seed | Jun 21, 2017 | ||||
Grant | Jun 21, 2017 |
Key People
Founding team and executive leadership
EnteroBiotix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Aberdeen | Seed |
| Gabriel Investments Ltd | Seed |
| Kineticos Ventures | Series A, Series B |
| Equity Gap | Series B, Seed |
| Scottish EDGE | Grant |
| Scottish National Investment Bank | Seed, Series A, Series B, Seed Round |
| Barwell Plc | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 62% MoM, reaching 3.7K.
- Jul 28, 2026
Monthly visitors grew 392% MoM, from 460 to 2.3K.
EnteroBiotix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EnteroBiotix's valuation, stock price, and market status.
Is Enterobiotix a public or private company?
Enterobiotix is a private company.
What is the current stock price of Enterobiotix?
Enterobiotix is a private company with no public stock price. No recent secondary market data is available.
How much is Enterobiotix worth (valuation)?
Valuation information for Enterobiotix is not publicly available.
Can I buy Enterobiotix stock?
Enterobiotix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enterobiotix's last funding round?
Enterobiotix's most recent funding round was Seed Round on April 9, 2026.
Who are the main investors in Enterobiotix?
Key investors in Enterobiotix include Equity Gap, Scottish National Investment Bank.
Will Enterobiotix IPO soon?
No public IPO plans have been announced for Enterobiotix.
How can I track Enterobiotix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enterobiotix's secondary market activity and sign up for updates.